Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Thymus Neoplasms 1Solid Tumor 1Mesothelioma 1Lung Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Adenocarcinoma 1

Interventions

tislelizumab 3Injections 2Fluorodeoxyglucose F18 2tumor-cells apoptosis factor, human 1toripalimab 1tazemetostat 1pembrolizumab 1enzalutamide 1envafolimab 1cemiplimab 1WW Domain-Containing Oxidoreductase 1Ultrasonography, Doppler 1Ultrasonography 1Radiotherapy 1Proton Therapy 1Oxaliplatin 1Off-Label Use 1Leucovorin 1Indocyanine Green 1Immune Checkpoint Inhibitors 1Histocompatibility Testing 1Fluorouracil 1Doxorubicin 1Cisplatin 1Carboplatin 1Blood Specimen Collection 1Bevacizumab 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Solid Tumor × Histocompatibility Testing × 90 days × Clear all
NCT06895681 2026-05-04

UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations

University of California, San Francisco

Not yet recruiting
50,000 enrolled
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡